Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease

Introduction: Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease characterized by progressive airflow limitation and associated with enhanced chronic inflammatory response of the airways to a variety of noxious stimuli. The current concept of COPD, however, ex...

Full description

Bibliographic Details
Main Authors: Priti Lokesh Meshram, Shivprasad N Shinde, Nagsen N Ramraje, Rohit R Hegde
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Lung India
Subjects:
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2018;volume=35;issue=1;spage=37;epage=40;aulast=Meshram
_version_ 1811322523901493248
author Priti Lokesh Meshram
Shivprasad N Shinde
Nagsen N Ramraje
Rohit R Hegde
author_facet Priti Lokesh Meshram
Shivprasad N Shinde
Nagsen N Ramraje
Rohit R Hegde
author_sort Priti Lokesh Meshram
collection DOAJ
description Introduction: Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease characterized by progressive airflow limitation and associated with enhanced chronic inflammatory response of the airways to a variety of noxious stimuli. The current concept of COPD, however, extends beyond the respiratory system to include a variety of extrapulmonary manifestations which includes raised inflammatory markers. Methods: This was a single, center observational open-labeled case–controlled study which included fifty patients of diagnosed COPD and 50 age- and gender-matched controls. All patients were evaluated by detailed history taking, pulmonary function test, 6-min walk test, and calculation of BODE scores. Levels of serum inflammatory markers such as cortisol, tumor necrosis factor alpha, interleukin-6 (IL-6), lactate dehydrogenase, and C-reactive protein were estimated using standard quality equipments. Observations: Majority of the patients in the study and control groups were males and were aged above 40 years. Thirty-eight of the fifty COPD patients had BODE scores of more than 3. All the studied inflammatory markers were significantly higher in the COPD group as compared to the control group. Of all the studied markers, only IL-6 showed a significant correlation with BODE index, i.e., higher IL-6 values were associated with higher BODE scores. No correlation was seen between the other markers and BODE scores. Conclusions: Our data suggest that IL-6 is a biomarker that correlates with BODE score. IL-6 as a target for therapy in COPD needs to be further studied. Follow-up studies are needed to validate findings.
first_indexed 2024-04-13T13:37:38Z
format Article
id doaj.art-0edcc16233cc47d6967aaeb632d9b6af
institution Directory Open Access Journal
issn 0970-2113
0974-598X
language English
last_indexed 2024-04-13T13:37:38Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Lung India
spelling doaj.art-0edcc16233cc47d6967aaeb632d9b6af2022-12-22T02:44:44ZengWolters Kluwer Medknow PublicationsLung India0970-21130974-598X2018-01-01351374010.4103/lungindia.lungindia_46_17Study of inflammatory markers and BODE index in chronic obstructive pulmonary diseasePriti Lokesh MeshramShivprasad N ShindeNagsen N RamrajeRohit R HegdeIntroduction: Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease characterized by progressive airflow limitation and associated with enhanced chronic inflammatory response of the airways to a variety of noxious stimuli. The current concept of COPD, however, extends beyond the respiratory system to include a variety of extrapulmonary manifestations which includes raised inflammatory markers. Methods: This was a single, center observational open-labeled case–controlled study which included fifty patients of diagnosed COPD and 50 age- and gender-matched controls. All patients were evaluated by detailed history taking, pulmonary function test, 6-min walk test, and calculation of BODE scores. Levels of serum inflammatory markers such as cortisol, tumor necrosis factor alpha, interleukin-6 (IL-6), lactate dehydrogenase, and C-reactive protein were estimated using standard quality equipments. Observations: Majority of the patients in the study and control groups were males and were aged above 40 years. Thirty-eight of the fifty COPD patients had BODE scores of more than 3. All the studied inflammatory markers were significantly higher in the COPD group as compared to the control group. Of all the studied markers, only IL-6 showed a significant correlation with BODE index, i.e., higher IL-6 values were associated with higher BODE scores. No correlation was seen between the other markers and BODE scores. Conclusions: Our data suggest that IL-6 is a biomarker that correlates with BODE score. IL-6 as a target for therapy in COPD needs to be further studied. Follow-up studies are needed to validate findings.http://www.lungindia.com/article.asp?issn=0970-2113;year=2018;volume=35;issue=1;spage=37;epage=40;aulast=MeshramBODEchronic obstructive pulmonary diseaseinflammatory markersinterleukin-6
spellingShingle Priti Lokesh Meshram
Shivprasad N Shinde
Nagsen N Ramraje
Rohit R Hegde
Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease
Lung India
BODE
chronic obstructive pulmonary disease
inflammatory markers
interleukin-6
title Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease
title_full Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease
title_fullStr Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease
title_full_unstemmed Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease
title_short Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease
title_sort study of inflammatory markers and bode index in chronic obstructive pulmonary disease
topic BODE
chronic obstructive pulmonary disease
inflammatory markers
interleukin-6
url http://www.lungindia.com/article.asp?issn=0970-2113;year=2018;volume=35;issue=1;spage=37;epage=40;aulast=Meshram
work_keys_str_mv AT pritilokeshmeshram studyofinflammatorymarkersandbodeindexinchronicobstructivepulmonarydisease
AT shivprasadnshinde studyofinflammatorymarkersandbodeindexinchronicobstructivepulmonarydisease
AT nagsennramraje studyofinflammatorymarkersandbodeindexinchronicobstructivepulmonarydisease
AT rohitrhegde studyofinflammatorymarkersandbodeindexinchronicobstructivepulmonarydisease